相似文献
1
Versatility of aminoglycosides and prospects for their future.
Clin Microbiol Rev. 2003 Jul;16(3):430-50. doi: 10.1128/CMR.16.3.430-450.2003.
2
Aminoglycoside-modifying enzymes.
Curr Opin Microbiol. 1999 Oct;2(5):499-503. doi: 10.1016/s1369-5274(99)00007-7.
3
Studies of enzymes that cause resistance to aminoglycosides antibiotics.
Methods Mol Med. 2008;142:261-71. doi: 10.1007/978-1-59745-246-5_20.
4
Bacterial resistance to aminoglycoside antibiotics.
Trends Microbiol. 1997 Jun;5(6):234-40. doi: 10.1016/S0966-842X(97)01033-0.
5
Modification of aminoglycoside antibiotics by clinical isolates of Streptococcus faecalis.
J Antibiot (Tokyo). 1981 Feb;34(2):224-30. doi: 10.7164/antibiotics.34.224.
6
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition.
Drug Resist Updat. 2001 Apr;4(2):106-17. doi: 10.1054/drup.2001.0197.
7
[Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
Antibiot Khimioter. 2004;49(5):11-23.
8
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
Microbiol Rev. 1993 Mar;57(1):138-63. doi: 10.1128/mr.57.1.138-163.1993.
9
[Future development of antibiotics. 3. Aminoglycoside antibiotics].
Nihon Rinsho. 1984 Mar;42(3):540-6.
10
[Types of aminoglycoside-inactivating enzymes of opportunistic strains of Enterobacteriaceae].
Antibiot Khimioter. 1991 Jan;36(1):16-20.
引用本文的文献
1
Total Synthesis of Kanamycins.
Chemistry. 2025 Jul 8;31(38):e202500685. doi: 10.1002/chem.202500685. Epub 2025 Apr 26.
2
A review of antibiotic safety in pregnancy-2025 update.
Pharmacotherapy. 2025 Apr;45(4):227-237. doi: 10.1002/phar.70010. Epub 2025 Mar 19.
3
Exploring molecular mechanisms of drug resistance in bacteria and progressions in CRISPR/Cas9-based genome expurgation solutions.
Glob Med Genet. 2025 Feb 16;12(2):100042. doi: 10.1016/j.gmg.2025.100042. eCollection 2025 Jun.
4
The Global Challenge of : Antimicrobial Resistance and Emerging Intervention Strategies.
Trop Med Infect Dis. 2025 Jan 16;10(1):25. doi: 10.3390/tropicalmed10010025.
5
A brief insight into species - a growing threat to public health.
Front Antibiot. 2023 Dec 5;2:1276982. doi: 10.3389/frabi.2023.1276982. eCollection 2023.
6
APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus.
ChemMedChem. 2025 Apr 14;20(8):e202400842. doi: 10.1002/cmdc.202400842. Epub 2025 Jan 26.
7
Phenotypic Differentiation Within the ' Aminoglycoside Resistance Gene Family Suggests a Novel Subtype IV of Contemporary Clinical Relevance.
Antibiotics (Basel). 2024 Dec 8;13(12):1196. doi: 10.3390/antibiotics13121196.
8
Prevalence and virulence of Vibrio parahaemolyticus isolated from clinical and environmental samples in Huzhou, China.
BMC Genomics. 2024 Dec 5;25(1):1187. doi: 10.1186/s12864-024-11106-3.
9
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections.
Drugs. 2025 Jan;85(1):21-40. doi: 10.1007/s40265-024-02104-6. Epub 2024 Nov 28.
10
The point mutation A1387G in the 16S rRNA gene confers aminoglycoside resistance in and .
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0083324. doi: 10.1128/aac.00833-24. Epub 2024 Oct 15.
本文引用的文献
1
Vancomycin resistance in staphylococci.
Drug Resist Updat. 1998;1(2):135-50. doi: 10.1016/s1368-7646(98)80029-0.
2
Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome.
Curr Protein Pept Sci. 2002 Feb;3(1):1-53. doi: 10.2174/1389203023380846.
3
New (and not so new) antibacterial targets - from where and when will the novel drugs come?
Curr Opin Pharmacol. 2002 Oct;2(5):513-22. doi: 10.1016/s1471-4892(02)00197-2.
4
R391: a conjugative integrating mosaic comprised of phage, plasmid, and transposon elements.
J Bacteriol. 2002 Sep;184(18):5158-69. doi: 10.1128/JB.184.18.5158-5169.2002.
5
Protein kinase inhibitors and antibiotic resistance.
Pharmacol Ther. 2002 Feb-Mar;93(2-3):283-92. doi: 10.1016/s0163-7258(02)00197-3.
6
Occurrence of antibiotic resistance gene cassettes aac(6')-Ib, dfrA5, dfrA12, and ereA2 in class I integrons in non-O1, non-O139 Vibrio cholerae strains in India.
Antimicrob Agents Chemother. 2002 Sep;46(9):2948-55. doi: 10.1128/AAC.46.9.2948-2955.2002.
7
Class 1 integron containing a new gene cassette, aadA10, associated with Tn1404 from R151.
Antimicrob Agents Chemother. 2002 Aug;46(8):2400-8. doi: 10.1128/AAC.46.8.2400-2408.2002.
8
Detection and characterization of class 1 integrons in enterohemorrhagic Escherichia coli.
Microb Drug Resist. 2002 Summer;8(2):85-91. doi: 10.1089/107662902760190626.
9
Genomic and functional analyses of SXT, an integrating antibiotic resistance gene transfer element derived from Vibrio cholerae.
J Bacteriol. 2002 Aug;184(15):4259-69. doi: 10.1128/JB.184.15.4259-4269.2002.
10
Genomics in anti-infective drug discovery--getting to endgame.
Curr Pharm Des. 2002;8(13):1099-118. doi: 10.2174/1381612023394845.
Zotero 插件